Either deletion of CXCR4 or CXCR7 leads to ventricular septum defects, showing that these two receptors are potential new intervention targets for studying certain cardiovascular diseases (Zou et al., 1998; Sierro et al., 2007). This evidence concerns the gene ACKR3 and cardiovascular disorder.